Search

Show 37692 results
Displaying 4181–4190 of 37692 results.
  • Our Research Impact
    Thomas J. Kelly

    Thomas J. Kelly, MD, PhD, is Director Emeritus of the Sloan Kettering Institute (SKI) and an Emeritus Member of the Molecular Biology Program of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center (MSK).

    … Job Title Emeritus Thomas J. Kelly, MD, PhD, is Director Emeritus of the Sloan Kettering Institute (SKI) and an Emeritus Member of the Molecular Biology Program of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center (MSK). He is internationally recognized for his pioneering work on

  • News
    What This Year’s Flu Season Means for Cancer Patients

    As flu season ramps up amid the continuing uncertainty of the COVID-19 pandemic, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the risks and what precautions they could take to safeguard against the flu.

    … Monday, November 16, 2020 As flu season ramps up amid the continuing uncertainty of the COVID-19 pandemic, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the risks and what precautions they could take to safeguard against the flu this year. The

  • Cell-Based Therapy

    Learn about the work Memorial Sloan Kettering scientists are doing in the area of cell-based therapy.

    … Immature nerve cells generated from induced pluripotent stem cells by cell engineering. Memorial Sloan Kettering researchers are at the forefront of developing cell-based therapies for cancer and other diseases, including central nervous system disorders. Immature nerve cells generated from induced pluripotent

  • Nibras Ahmed

    … Education BA, CUNY Hunter College, Cancer Biology Degree BA Start Year 2025 Email [email protected]

  • Amy Devigne

    Memorial Sloan Kettering nurse practitioner Amy Devigne specializes in caring for people who have had lung or esophageal cancer.

    … Job Title Nurse Practitioner I am a board-certified nurse practitioner (NP) with special training in thoracic surgery and thoracic cancer survivorship issues.  I began my career at MSK as a thoracic registered nurse (RN) in 1995. A graduate of Columbia University’s nurse practitioner program, I have

  • George Naoum
    Radiation Oncologist
    George Naoum

    I am a radiation oncologist who has special training in using radiation therapy to treat cancer. I am an expert in the latest techniques, including external beam radiotherapy, stereotactic radiotherapy, and proton therapy, with a special focus on treating breast cancer. I see patients at the Memorial Sloan Kettering Bergen location in New Jersey.

    … Radiation Oncologist Job Title Assistant Attending Physician I am a radiation oncologist who has special training in using radiation therapy to treat cancer. I am an expert in the latest radiation therapy techniques, including external beam radiotherapy, stereotactic radiotherapy, and proton therapy,

  • George Naoum
    Radiation Oncologist
    George Naoum

    Soy oncólogo de radioterapia con formación especializada en el uso de la radioterapia para el tratamiento contra el cáncer. Soy experto en las técnicas más recientes, lo que incluye la radioterapia de haz externo, la radioterapia estereotáctica y la terapia de protones, con especial énfasis en el tratamiento del cáncer de mama. Atiendo pacientes en el Memorial Sloan Kettering Bergen de Nueva Jersey.

    … Radiation Oncologist Job Title Médico adjunto asistente Soy oncólogo de radioterapia con formación especializada en el uso de la radioterapia para el tratamiento contra el cáncer. Soy experto en las técnicas de radioterapia más recientes, lo que incluye la radioterapia de haz externo, la radioterapia

  • Clinical Trial
    A Phase III Study Comparing Standard Chemotherapy to Treatment with CPX-351 and/or Gilteritinib for Children Newly Diagnosed with Acute Myeloid Leukemia

    … Full Title A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations (AAML1831) (CIRB) Purpose Daunorubicin, cytarabine, and gemtuzumab

  • The Joan Massagué Lab
    David Ralph

    … Job Title Senior Director, Drug and Diagnostic Development, Navidea, Columbus, OH Degree PhD Start Year 1987 End Year 1991

  • News
    Investigators Sequence the Genome of a Rare Head and Neck Cancer

    Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.

    … Friday, May 24, 2013 Summary Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering. Since the completion of the Human Genome Project in 2003, many researchers